ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 700363 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 700363; 2) Community: the network communities that were significantly associated with the response to NSC 700363; 3) Molecule: the relationships between components within communities and NSC 700363; 4) MDR: the compounds that were significantly associated with the NSC 700363.

NSC Compound Enrichment Correlation
NSC 681639 Camptothecin Derivative 0.00366577979610627 0.69135189
NSC 700584 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-diselone, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.00407837248037199 0.20173124
NSC 709237 Camptothecin Derivative 0.00407837248037199 0.62254499
NSC 721514 2-(N,N-bis(2-chloroethyl)phosphorodiamidoxy)methyl-1-methyl- 5-methoxyindole-4,7-dione 0.00407837248037199 0.5656907
NSC 723531 Resveratrol-3,5-diacetate 0.00407837248037199 0.15827631
NSC 736401 Null 0.00407837248037199 0.35888699
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.00407837248037199 0.68176689
NSC 287459 Cytarabine AY 0.00407837248037205 0.59189502
NSC 33566 Null 0.00407837248037205 -0.075309313
NSC 681638 Camptothecin Derivative 0.00407837248037205 0.68359019
Total:69  Current:10    [First] [Prev] [Next] [Last]